K Number
K081386
Device Name
MODEL 6150 (MYLAB70) AND MODEL 6100 (MYLAB90)
Manufacturer
Date Cleared
2008-09-25

(129 days)

Product Code
Regulation Number
892.1550
AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP Authorized
Intended Use
Esaote's Model 6150 (MyLab70) and Model 6100 (MyLab90) are mainframe ultrasound systems used to perform diagnostic general ultrasound studies including Cardine unc Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Intraoperative: Abdominal, and Other: Urologic. Additionally, the MyLab90 is indicated for Laparoscopic use. The Virtual Navigator is a MyLab optional license that provides additional image information from a second modality like CT or MR, during a clinical ultrasond session. The second modality provides additional security in assessing the morphalogy of the ultrasound image. Virtual Navigator can be used in the following application: Abdominal, Musculo-skeletal, Urologic, and Vascular. The second modality image is not intended to be used as a standalone diagnostic image since it represents information of a patient that could not be congreent with the current (actual) patient position and shall therefore always been as an additional source of information. The Virtual Navigator tracking system should not be used on or around persons with a cardiac pacemaker, and should not be used around life supporting equipment.
Device Description
The MyLab70 and MyLab90 system designs remain the same as those previously cleared by FDA via K051837, K051308, and K060827, respectively, except for those features being added via this submission. They are compact ultrasound systems used to perform diagnostic general ultrasound studies. Their primary modes of operation are: B-Mode, M-Mode, Doppler and Color Flow Mapping and, on lower frequency probes and, Tissue Enhancement Imaging (CE), The systems are equipped with an optional LCD Color Display and can drive phased (PA), convex (CA) and linear array (LA) and Doppler probes. The MyLab70 and MyLab90 systems are able to produce Real Time 2D images and 3D images (in manual mode) with all probes. The MyLab70 and MyLab90 systems are manufactured under an ISO 9001:2000 and ISO 13485 certified quality system.
More Information

No
The document describes standard ultrasound imaging and a "Virtual Navigator" feature that overlays images from other modalities (CT/MR) for additional information. There is no mention of AI or ML being used for image analysis, interpretation, or any other function.

No
The device is described as a "diagnostic general ultrasound system" used to "perform diagnostic general ultrasound studies," indicating its purpose is for diagnosis, not therapy.

Yes
The "Intended Use / Indications for Use" section explicitly states that the systems are "used to perform diagnostic general ultrasound studies."

No

The device is described as a "mainframe ultrasound system" with various hardware components like probes and displays. While it includes a "Virtual Navigator" software license, the core device is a hardware system.

Based on the provided text, this device is not an IVD (In Vitro Diagnostic).

Here's why:

  • IVD definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases or other conditions.
  • Device function: The description clearly states that the MyLab systems are "mainframe ultrasound systems used to perform diagnostic general ultrasound studies." Ultrasound is an imaging modality that uses sound waves to create images of internal body structures. The Virtual Navigator adds information from other imaging modalities (CT, MR) to the ultrasound image.
  • Lack of mention of samples: There is no mention of the device analyzing samples taken from the body. Its function is based on external imaging techniques.

Therefore, the device falls under the category of medical imaging equipment, not in vitro diagnostics.

N/A

Intended Use / Indications for Use

Esaote's Model 6150 (MyLab70) and Model 6100 (MyLab90) are mainframe ultrasound systems used to perform diagnostic general ultrasound studies including Cardine unc Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Intraoperative: Abdominal, and Other: Urologic. Additionally, the MyLab90 is indicated for Laparoscopic use.

The Virtual Navigator is a MyLab optional license that provides additional image information from a second modality like CT or MR, during a clinical ultrasond session. The second modality provides additional security in assessing the morphalogy of the ultrasound image.

Virtual Navigator can be used in the following application: Abdominal, Musculo-skeletal, Urologic, and Vascular.

The second modality image is not intended to be used as a standalone diagnostic image since it represents information of a patient that could not be congreent with the current (actual) patient position and shall therefore always been as an additional source of information.

The Virtual Navigator tracking system should not be used on or around persons with a cardiac pacemaker, and should not be used around life supporting equipment.

Product codes

90IYN, 90IYO, ITX

Device Description

The MyLab70 and MyLab90 system designs remain the same as those previously cleared by FDA via K051837, K051308, and K060827, respectively, except for those features being added via this submission.

They are compact ultrasound systems used to perform diagnostic general ultrasound studies. Their primary modes of operation are: B-Mode, M-Mode, Doppler and Color Flow Mapping and, on lower frequency probes and, Tissue Enhancement Imaging (CE), The systems are equipped with an optional LCD Color Display and can drive phased (PA), convex (CA) and linear array (LA) and Doppler probes.

The MyLab70 and MyLab90 systems are able to produce Real Time 2D images and 3D images (in manual mode) with all probes. The MyLab70 and MyLab90 systems are manufactured under an ISO 9001:2000 and ISO 13485 certified quality system.

Mentions image processing

Yes

Mentions AI, DNN, or ML

Not Found

Input Imaging Modality

Ultrasound, CT, MR

Anatomical Site

Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Other: Urologic, Laparoscopic, Ophthalmic, Intraoperative Neurological, Transurethral, Extravascular, Intravascular, Scrotal

Indicated Patient Age Range

Adult, Pediatric, Neonatal (Cephalic)

Intended User / Care Setting

Not Found

Description of the training set, sample size, data source, and annotation protocol

Not Found

Description of the test set, sample size, data source, and annotation protocol

Not Found

Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)

Not Found

Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)

Not Found

Predicate Device(s)

K070106, K062086, K042391, K012564, K042512

Reference Device(s)

K051308, K051837, K060827, K013722

Predetermined Change Control Plan (PCCP) - All Relevant Information

Not Found

§ 892.1550 Ultrasonic pulsed doppler imaging system.

(a)
Identification. An ultrasonic pulsed doppler imaging system is a device that combines the features of continuous wave doppler-effect technology with pulsed-echo effect technology and is intended to determine stationary body tissue characteristics, such as depth or location of tissue interfaces or dynamic tissue characteristics such as velocity of blood or tissue motion. This generic type of device may include signal analysis and display equipment, patient and equipment supports, component parts, and accessories.(b)
Classification. Class II.

0

K081386

510(k) Summary MyLab70, 90 Systems Esaote. S.p.A.

SEP 2 5 2008

510(k) Summary

The following 510(k) summary has been prepared pursuant to requirements specified in 21CFR 807.92(a).

807.92(a)(1)

Submitter Information

Allison Scott The Anson Group 11460 N Meridian St., Ste 150 Carnel, Indiana 46032 Phone: (317) 569-9500 x106 Facsimile: (317) 569-9520 Ascott(a)ansongroup.com

Contact Person: Allison Scott

Date: August 12, 2008

807.92(a)(2)

Trade Name: MyLab70 & MyLab90 Systems

Common Name: Ultrasound Imaging System

Classification Name(s): Ultrasonic pulse doppler imaging system 892.1550 Ultrasonic pulsed echo imaging system 892.1560

Classification Number: 90IYN; 90IYO

807.92(a)(3)

Predicate Device(s)

| K070106, K062086,
K042391, K012564, and

K042512BrainLabIGSonic
K051308MyLab70Esaote, S.p.A
K051837MyLab90Esaote, S.p.A
K060827MyLab 70, 90Esaote, S.p.A
K013722RVSHitachi

1

510(k) Summary MyLab70, 90 Systems Esaote, S.p.A.

807.92 (a)(4)

Device Description

The MyLab70 and MyLab90 system designs remain the same as those previously cleared by FDA via K051837, K051308, and K060827, respectively, except for those features being added via this submission.

They are compact ultrasound systems used to perform diagnostic general ultrasound studies. Their primary modes of operation are: B-Mode, M-Mode, Doppler and Color Flow Mapping and, on lower frequency probes and, Tissue Enhancement Imaging (CE), The systems are equipped with an optional LCD Color Display and can drive phased (PA), convex (CA) and linear array (LA) and Doppler probes.

The MyLab70 and MyLab90 systems are able to produce Real Time 2D images and 3D images (in manual mode) with all probes. The MyLab70 and MyLab90 systems are manufactured under an ISO 9001:2000 and ISO 13485 certified quality system.

807.92(a)(5)

Intended Use(s)

Esaote's Model 6150 (MyLab70) and Model 6100 (MyLab90) are mainframe ultrasound systems used to perform diagnostic general ultrasound studies including Cardine unc Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Intraoperative: Abdominal, and Other: Urologic. Additionally, the MyLab90 is indicated for Laparoscopic use.

The Virtual Navigator is a MyLab optional license that provides additional image information from a second modality like CT or MR, during a clinical ultrasond session. The second modality provides additional security in assessing the morphalogy of the ultrasound image.

Virtual Navigator can be used in the following application: Abdominal, Musculo-skeletal, Urologic, and Vascular.

The second modality image is not intended to be used as a standalone diagnostic image since it represents information of a patient that could not be congreent with the current (actual) patient position and shall therefore always been as an additional source of information.

The Virtual Navigator tracking system should not be used on or around persons with a cardiac pacemaker, and should not be used around life supporting equipment.

2

510(k) Summary
MyLab70, 90 Systems
Esaote. S.p.A.

807.92(a)(6)

Technological Characteristics

: : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : : :

| | Hitachi RVS
K013722
Predicate | IGSonic
BrainLab
K012564
Predicate | Esaote
MyLab 90
(6100)
K051837 | Esaote
MyLab 70
(6150)
K051308 |
|-------------------------------|-------------------------------------|---------------------------------------------|-----------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------|
| Virtual Navigator
software | YES | YES | To be cleared with
this submission | To be cleared
with this
submission |
| Primary application | Abdominal | NeuroSurgery | Abdominal,
Musculoskeletal
Conventional and
Superficial,
Peripheral Vascular
and, Urologic | Abdominal,
Musculoskeletal
Conventional &
Superficial.
Peripheral
Vascular and,
Urologic |
| Tracking System | Electromagnetic
(Ascension) | Optical (NDI) | Electromagnetic
(Ascension) | Electromagnetic
(Ascension) |
| Registration
Procedure | External Marker

  • one scan plane | External
    Marker | External and
    Internal Marker,
    one scan plane | External and
    Internal Marker,
    one scan plane |

3

DEPARTMENT OF HEALTH & HUMAN SERVICES

Image /page/3/Picture/15 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, along with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES . USA" arranged in a circular pattern around the eagle. The logo is black and white.

Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850

SEP 2 5 2008

Esaote, S.p.A. % Mr. Mark Job Responsible Third Party Official Regulatory Technology Services LLC 1394 25th Street NW BUFFALO MN 55313

Re: K081386

Trade/Device Name: MyLab70 and MyLab90 Systems Regulation Number: 21 CFR 892.1550 Regulation Name: Ultrasonic pulsed doppler imaging system Regulatory Class: II Product Code: IYN, IYO, and ITX Dated: September 9, 2008 Received: September 10, 2008

Dear Mr. Job:

We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and we have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.

This determination of substantial equivalence applies to the following transducers intended for use with the MyLab70 and MyLab90 Systems, as described in your premarket notification:

Transducer Model Number

CA 421CA 631LA 523
CA 430EC 123LA 532
CA 431LA 435PA 122
CA 621LA 522PA 230

If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.

Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all

4

Page 2 - Mr. Mark Job

the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the clectronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.

This determination of substantial equivalence is granted on the condition that prior to shipping the first device, you submit a postclearance special report. This report should contain complete information, including acoustic output measurements based on production line devices, requested in Appendix G, (enclosed) of the Center's September 30, 1997 "Information for Manufacturers Seeking Marketing Clearance of Diagnostic Ultrasound Systems and Transducers." If the special report is incomplete or contains unacceptable values (e.g., acoustic output greater than approved levels), then the 510(k) clearance may not apply to the production units which as a result may be considered adulterated or misbranded.

The special report should reference the manufacturer's 510(k) number. It should be clearly and prominently marked "ADD-TO-FILE" and should be submitted in duplicate to:

Food and Drug Administration Center for Devices and Radiological Health Document Mail Center (HFZ-401) 9200 Corporate Boulevard Rockville, Maryland 20850

This letter will allow you to begin marketing your device as described in your premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus permits your device to proceed to market.

If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (240) 276-0120. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (240) 276-3150 or at its Internet address http://www.fda.gov/cdrh/industry/support/index.html

If you have any questions regarding the content of this letter, please contact Ms. Lauren Hefner at (240) 276-3666.

Sincerely yours,

Ioque M. Whay

Joyce M. Whang, Ph.D Acting Director, Division of Reproductive, Abdominal and Radiological Devices Office of Device Evaluation Center for Devices and Radiological Health

5

Indications for Use

510(k) Number (if known):

Device Name: MyLab70 and MyLab90 Systems

Indications For Use:

Esaote's Model 6150 (MyLab70) and Model 6100 (MyLab90) are mainframe ultrasound systems used to perform diagnostic general ultrasound studies including Cardiac, Transesophageal, Peripheral Vascular, Neonatal Cephalic, Adult Cephalic, Small organ, Musculoskeletal (Conventional and Superficial), Abdominal, Fetal, Transvaginal, Transrectal, Pediatric, Intraoperative: Abdominal, and Other: Urologic. Additionally, the MyLab90 is indicated for Laparoscopic use.

The Virtual Navigator is a MyLab optional license that provides additional image information from a second modality like CT or MR, during a clinical ultrasound session. The second modality provides additional security in assessing the morphology of the ultrasound image.

Virtual Navigator can be used in the following application: Abdominal, Musculo-skeletal, Urologic, and Vascular.

The second modality image is not intended to be used as a standalone diagnostic image since it represents information of a patient that could not be congruent with the current (actual) patient position and shall therefore always been seen as an additional source of information.

The Virtual Navigator tracking system should not be used on or around persons with a cardiac pacemaker, and should not be used around life supporting equipment.

Prescription Use _ X (Part 21 CFR 801 Subpart D)

AND/OR

Over-The-Counter Use (21 CFR 807 Subpart C)

(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE IF NEEDED)

Concurrence of CDRH, Office of Device Evaluation (ODE)

Arzuh Mry

Page 1 of 1

(Division Sign-Off)
Division of Reproductive, Abdominal,
and Radiological Devices
510(k) Number K08/386

8A

6

lyLab90 & 70XV

Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTiOther (specify)
OphthalmicPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12
FetalPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
AbdominalPPK051837K051837PPPK051837K051837K0518376, 8, 9, 12, 13
Intraoperative (Abdominal)PPK051837K051837PPPK051837K051837K0518376, 8, 9, 12, 13
Intraoperative NeurologicalPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
PediatricPPK051837K051837PPPK051837K051837K0518376, 8, 9, 12, 13
Small Organ [1]PPK051837K051837PPPK051837K051837K0518376, 8, 9, 12
Neonatal CephalicPPK051837K051837PPPK051837K051837K0518376, 8, 9, 12
Adult CephalicPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12
Cardiac [2] (MtF369)PPK051837K051837PPPK051837K051837K0518376, 8, 9, 12
Transesophageal (Cardiac)PPK051837K051837PPPK051837K051837K0518376, 8, 9, 12, 13
Transesophageal (Non Cardiac)PPK051837K051837PPPK051837K051837K0518376, 8, 9, 12
TransrectalPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13, 14
TransvaginalPPK051837K051837PPPK051837K051837K0518376, 8, 9, 12
TransurethralPPK051837K051837PPPK051837K051837K0518376, 8, 9, 12, 13
ExtravascularPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
Peripheral VascularPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
LaparoscopicPPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
Musculo-skeletal Conventional [3]PPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
Musculo-skeletal Superficial [3]PPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
Other (Urological)PPK051837K051837PPPK051837K051837K0518376, 7, 8, 9, 12, 13
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
FetalP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K051837K0518376, 8, 9, 12
AbdominalP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K051837K0518376, 8, 9, 12
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K051837K0518376, 8, 9, 12
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K051837K0518376, 8, 9, 12
LaparoscopicK051837
Musculo-skeletal Conventional [3]P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374MtF374MtF3746, 8, 9, 12
Musculo-skeletal Superficial [3]P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374MtF374MtF3746, 8, 9, 12
Other (Urological)P
K051837P
K051837P
K051837P
K051837P
K051837K051837K0518376, 8, 9, 12
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
OphthalmicPPPP
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
FetalP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
AbdominalPPPP
K051837P
K051837P
K051837P
K051837P
K051837
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF3746,8,9,12
Small Organ (1)
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
Laparoscopic
Musculo-skeletal Conventional [3]P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF3746,8,9,12
Musculo-skeletal Superficial [3]P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF3746,8,9,12
Other (Urological)P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF374P
MtF3746,8,9,12

Concurrence of CDRH, Office of Device Evaluation (ODE

[7] 4D K060827 & MtF369

[3] Musculo Skeletal includes Nerve Block

MtE377

(14) IMT MtF374

(12) Compound K051837 [9] XView K051837

(Division Sign-Off) F

7

Lab90 & 70XVG - CA4

Concurrence of CDRH, Office of Device Evaluation (ODE [12] Compound K051837 [4] Combined modes
[4] Combined modes
are:B+M+PW+CFM+PD
[6] 3D K051837

[9] XView - K051837

[3] Musculoskeletal - Nerve Block

TRAINING SAMPLE PICTURE - DOCUMENT TYPE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

8

MyLab90 & 70XVG - CA43

RESEARCH LIBRARY - PSYCHOLOGY

(3) Musculoskeletal - Nerve Block
(4) 30 Musculoskeletals - Republikas (4) 30 Maria Maria Maria Maria Maria Maria Maria Maria Maria Maria Mari Componima Kossi Componumar (12

e:B+M+PW+CFM+P
rel.sb.krcss

[g]3DK051837

913DK051837
147-171

8J vpan - MTF-374

}Xyview - KD51837

121, Compound K05183

12] Compound K051837

[112] Compound K05183?

L2] Compound K051837

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081 386

9

1
1
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
OphthalmicPPPPPPPPPP6, 8, 9
FetalMtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF3296, 8, 9
AbdominalPPPPPPPPPP6, 8, 9
Intraoperative (Abdominal)MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF329MtF3296, 8, 9
Intraoperative Neurological
PediatricPPPPPPPP6, 8, 9
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularPPPPPPPP6, 8, 9
MtF329MtF329MtF329MtF329MtF329MtF329MtF329
Laparoscopic
Musculo-skeletal Conventional [3]PPPPPPMtF329P6, 8, 9
MtF329MtF329MtF329MtF329MtF329MtF329MtF329
Musculo-skeletal Superficial [3]PPPPPPMtF329P6, 8, 9
MtF329MtF329MtF329MtF329MtF329MtF329MtF329
Other (Urological)PPPPPPMtF3296, 8, 9
MtF329MtF329MtF329MtF329MtF329MtF329
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
OphthalmicPPPPPPPPP
FetalPK051837K051837K051837K051837K051837K051837P6, 8, 9, 12
AbdominalPK051837K051837PPPK051837P6, 8, 9, 12
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricMtF374MtF374MtF374MtF374 PMtF374 PMtF374MtF374P6,8,9,12
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularPK051837K051837K051837K051837K051837K051837P6, 8, 9, 12
Laparoscopic
Musculo-skeletal Conventional [3]MtF374MtF374MtF374MtF374 PMtF374 PMtF374MtF374P6,8,9,12
Musculo-skeletal Superficial [3]MtF374MtF374MtF374MtF374 PMtF374MtF374MtF374P6,8,9.12
Other (Urological)P
K051837K051837K051837K051837K051837KOS1837K051837P6, 8, 9, 12
N = New; P = Previously Cleared by FDA

New, P = Previously Cleared by FDA

N = New; P = Previously Cleared
(4) Cousbilled kenetal - Nerve Block
(4) Cousbilled Kenetal - Nerve Block
(4) Cousbilled Marine Marive Block
(6) 3D KOS 1837 (7) 14 - 1
(9)

A] Musculocutaneous NERVE DIVISION
B] Combined mcps

[4] combined modes

[24] COMBINED MODES
are: R-M+PW-CFM+PD

e:B.+M.+PW.+CFM+PD

[8] YBan, MTE 372

pydantic - Mtf 374

31xyiew - KDS1837

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

10

yLab90 & 70 XVG - CA62

N = New; P = Previously Cleared by FDA

Intermolecular, Noncovalent

[3] Muscullesteletals: Nerve Block
[6] Muscullest Latin Marve Block
[6] 30 Kost Latin Market Status Creditorial Research
[18] Virgin - TVTF 333 1
[32] Componimo Rouss Brass

[4] Combined modes

e.B+M+PW+CFM+P

[6]3DK051837
RIC,D.M.C.INT

3DK051837

el ypan - MTF374
5D K02857

Oran - NIF 374
XYYview - K051837

[6] Xylem + K051837

[16] XYVIEW - K051837

3] Compound K051837

Concurrence of CDRH, Office of Device Evaluation (ODB

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

11

CA631
l
70XVG
&
MyLab90

| Clinical Application | B | M | PWD | CWD | Color Doppler | Amplitude
Doppler | Combined [4] | Color Velocity
Mapping (TVM) | Tissue Enhacement Imaging
(TEI) | CnTl | Other
(specify) |
|-----------------------------------|-------------|-------------|-------------|-----|---------------|----------------------|--------------|---------------------------------|------------------------------------|-------------|--------------------|
| Ophthalmic | P | P | P | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P | 6,8,9 |
| Fetal | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |
| Abdominal | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |
| Intraoperative (Abdominal) | | | | | | | | | | P
MtF369 | |
| Intraoperative Neurological | | | | | | | | | | | |
| Pediatric | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | |
| Small Organ [1] | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Cardiac [2] | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | | |
| Transrectal | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | |
| Peripheral Vascular | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |
| Laparoscopic | | | | | | | | | | | |
| Musculo-skeletal Conventional [3] | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |
| Musculo-skeletal Superficial [3] | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |
| Other (Urological) | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | P
MtF369 | | P
MtF369 | P
MtF369 | 6,8,9 |

= New, P.P., Previously, Cleared by DPC

[3] Musculoskeletal - Nerve Block
(4) Gombined models modes
(4) Gambined (Frodes
(4) Kraft Krailero
(8) VPan - MTT 3374
(8) VPan - MTT 3374
(8) XView - K0513837

  1. Combined modes

[4] COMBINED MODES
ars.R+M+PW+FEM+PF

hre.p+M+PY+W+F+M+
rc1.3D K051827

[8] yp3n - MTF32/

YVRAI-MTF374
VVJIAW VUE1937

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices K081386
510(k) Number

12

t1
1
1
=
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
-
-
1
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
1

| Clinical Application | B | M | PWD | CWD | Color Doppler | Amplitude
Doppler | Combined [4] | Color Velocity
Mapping (TVM) | Tissue Enhacement
Imaging (TEI) | CnTI | Other
(specify) |
|-----------------------------------|--------------|--------------|--------------|-----|---------------|----------------------|--------------|---------------------------------|------------------------------------|--------------|--------------------|
| Ophthalmic | | | | | | | | | | | |
| Fetal | K051837
P | K051837
P | K051837
P | | P
K051837 | P
K051837 | P
K051837 | | P
K051837 | P
K051837 | 6, 8, 9, 12 |
| Abdominal | | | | | | | | | | | |
| Intraoperative (Abdominal) | | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | | |
| Pediatric | | | | | | | | | | | |
| Small Organ [1] | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Cardiac [2] | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | | |
| Transrectal | P
K051837 | P
K051837 | P
K051837 | | P
K051837 | P
K051837 | P
K051837 | | P
K051837 | KOS1837
P | 6, 8, 9, 12 |
| Transvaginal | P
K051837 | P
K051837 | P
K051837 | | P
K051837 | P
K051837 | P
K051837 | | K051837
P | K051837
P | 6, 8, 9, 12 |
| Transurethral | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | |
| Peripheral Vascular | | | | | | | | | | | |
| Laparoscopic | | | | | | | | | | | |
| Musculo-skeletal Conventional [3] | | | | | | | | | | | |
| Musculo-skeletal Superficial [3] | | | | | | | | | | | |
| Other (Urological) | P
K051837 | P | P
K051837 | | P | P | P | | P
K051837 | P | 6, 8, 9, 12 |

N = New; P = Previously Cleared by

Combined modes are:

[4] Combined modes are:
B+M+PW+CFM+PD
[6] 3D K051837

[6] 3DK051837

[8] ypan - MITF37

[8] VPan - MTF 374
[9] XView - K051837
[12] Compound - K051837
[12] Compound - K051837

COMPOUND REFRACTIVITY

Concurrence of CDRH, Office of Device Evaluation (ODE

Joy
(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

13

1
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
MtF329P
MtF329P
MtF329P
MtF329MtF329MTF 329
P6, 8, 9, 13
Small Organ [1]P
MtF329P
MtF329P
MtF329P
MtF329MtF329MTF 329
P6, 8, 9, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
MtF329P
MtF329P
MtF329P
MtF329MtF329MTF 329
P6, 8, 9, 13
Laparoscopic
Musculo-skeletal Conventional [3]P
MtF329P
MtF329P
MtF329P
MtF329MtF329MTF 329
P6, 8, 9, 13
Musculo-skeletal Superficial [3]P
MtF329P
MtF329P
MtF329P
MtF329MtF329MTF 329
P6, 8, 9, 13
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Small Organ [1]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13,
14
Laparoscopic
Musculo-skeletal Conventional [3]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Musculo-skeletal Superficial [3]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Other (Urological)
N = New; P = Previously Cleared by FDA
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K0518376, 8, 9, 12, 13
Small Organ [1]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K0518376, 8, 9, 12, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K0518376, 8, 9, 12, 13, 14
Laparoscopic
Musculo-skeletal Conventional [3]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K0518376, 8, 9, 12, 13
Musculo-skeletal Superficial [3]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837K0518376, 8, 9, 12, 13
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Small Organ [1]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12, 13
Laparoscopic
Musculo-skeletal Conventional [3]P
MtF369P
MtF369P
MtF369P
MtF369P
MtF369P
MtF369P
MtF3696, 8, 9, 12, 13
Musculo-skeletal Superficial [3]
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
Small Organ [1]
Neonatal CephalicP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
Adult Cephalic
Cardiac [2]P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K051837P
K0518376, 8, 9, 12
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTiOther (specify)
Ophthalmic
Fetal
AbdominalK051837PPPK051837K0518376, 8, 9, 12
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult CephalicK051837PPK051837K051837K051837PK051837K0518376, 8, 9, 12
Cardiac [2]K051837PPK051837K051837K051837PK051837K0518376, 8, 9, 12
Adult Cephalic
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularMTF369PPMTF369MTF369MTF369PMTF369MTF3696, 8, 9, 12
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)
Clinical ApplicationBMPWDCWDColor
DopplerAmplitude
Doppler (PD)Combined [4]Color Velocity
Mapping (TVM)
K052805 & MtF323Tissue
Enhancement
Imaging (TEI)
MtF323CnTI
K052805 &
MtF323Other
(specify)
OphthalmicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
FetalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12
AbdominalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528056, 8, 9, 12, 13
Intraoperative (Abdominal)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
Intraoperative NeurologicalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 8, 9, 12
Small Organ [1]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 9, 12
Neonatal CephalicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12
Adult Cephalic (MtF346)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 9, 12
Cardiac [2] (MtF356)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12
Transesophageal (Cardiac)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 9, 12
Transesophageal (Non Cardiac)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 8, 9, 12, 13
TransrectalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 8, 9, 12
TransvaginalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 8, 9, 12
TransurethralP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13, 14
IntravascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
LaparoscopicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
Musculo-skeletal Conventional [3]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
Musculo-skeletal Superficial [3]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
Other (Urological)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K052805P
K051308P
K0528055, 6, 7, 8, 9, 12, 13
N = New; P = Previously Cleared by FDA
[1] Small Organs includes Breast, Thyroid and
[2] Cardiac is Adult and Pediatric
[3] Musculo Skeletal - Nerve Block- K071996
[4] Combined modes are: B+M+PW+CW+CFM+PD
[6] 3D K060827
[7] 4D K060827 MtF356
[8] VPan K052805, MtF323 & 374
[9] XView MtF336
[10] Stress K051308
[11] Xstrain K060827
[12] Compound Imaging - K052805
[13] TP-View - MTF#374
[14] IMT - MTF#331 & 374
[15] Automatic Gain - MTF#374

Concurrence of CDRH, Office of Device Evaluation (ODE)

Wh

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

14

yLab90 & 70XVG - LA52

[9] XView - K051837
[12] Compound - K051837
[13] TP-View -MTF 374 (14) IMT -MTF 374 [8] VPan - MTF 374 [3] Musculoskeletal - Nerve Block
[4] Combined modes are:
B+M+PW+CFM+PD
[6] 3D - K060827 & MTF 369 [1] Small Organs includes Breast
and Testicles
[2] Cardiac is Adult and Pediatric

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)

Division of Reproductive, Abdominal and
Radiological Devices

510(k) Number

K081386

Tout m wly

15

MyLab90 & 70XVG - LA52

Concurrence of CDRH, Office of Device Evaluation (ODE)

[4] Combined modes are:
B+M+PW+CFM+PD

Prescription Use (Per 21 CFR 801.109)

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386
Why

16

1yLab90 & 70XVG - LA53

[9] XView - K051837
[12] Compound - K051837 [13] TP-View - MTF 374 [1] Small Organs includes Breast, Treast, Treast, Treast, Treasti Trasticles
[3] Tresticles
[3] Comedical modes are:
[3] Comber modes are:
[6] 3D K051837

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

17

lyLab90 & 70XVG-PA12

ીની સા [1] Small Organs includes Breast, Thyre
and Testicles
[2] Cardiac is Adult and Pediatric

(616)-447-3714

[8] VPan MTF 374

[9] XView K051837
[12] Compound K051837

[3] Musculoskeletal - Nerve Block
[4] Combined modes are:
B+M+PW+CW+CFM+PD

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

18

MyLab90 & XVG - PA236

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
W
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

Division of Reproductive
Radiological Devices
510(K) Number

19

MyLab70

Concurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off) 17
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

20

ﺮﺍ
CA42
l
0
1
Mode of Operations
nical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
OphthalmicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
etalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
dominalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
raoperative (Abdominal)
raoperative Neurological
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
Laparoscopic
Musculo-skeletal Conventional [3]P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF3566, 8, 9
Musculo-skeletal Superficial [3]P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF3566, 8, 9
(Urological)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PP
K0513086, 8, 9
N = New; P = Previously Cleared by FDA

Musculo Skeletal - Nerve Block

X
Y
Z

4] Combined modes are:

[3] Musculo Skeletal - Nerve Block
[4] Copyright M4CF M400Es are:
[4] Copyright M4CF M400Es are:
[6] Strikit P356 23
[8] VPan - M7 255 233
[9] XView - MTF 3336

B+M+PY+5CM+9D

[6] 3D-MTF-356

[8] ypan - MTF323

[16] XView - MTF 336

Concurrence of CDRH, Office of Device Evaluation (ODF

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number K081386

21

CA430
I
0
1
Mode of Operations
nical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
OphthalmicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K0513086, 8, 9
RetinalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K0513086, 8, 9
AbdominalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF3236, 8, 9
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
MtF347P
MtF347P
MtF347P
MtF347P
MtF347P
MtF347P
MtF3476, 8, 9
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF3236, 8, 9
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)P
MtF347P
MtF347P
MtF347P
MtF347P
MtF347P
MtF347P
MtF3476, 8, 9

10-NEW-2-PHYSICIAN'S CHOICE

N = New; P = New; P = Pre
B+M+PWineFl modes arous
(6) 3D - Mitf 3:30 - Mitres are
(6) 3D - Mitr 3:35
(8) VPan - Mirr 3:33
(8) VPan - Mirr 3:23 (8) Trip 3:36

+MPW+CFM+PD

16I3D-MTF-356

[R] VYPR - MTFE 373

pixview - MTP 335

Concurrence of CDRH, Office of Device Evaluation (OD

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

22

I
CA43
1
70

| Clinical Application | B | M | PWD | CWD | Color Doppler | Amplitude
Doppler | Combined [4] | Color Velocity
Mapping (TVM) | Tissue Enhacement Imaging
(TEI) | CnTI | Other
(specify) |
|-----------------------------------|--------|--------|--------|--------|---------------|----------------------|--------------|---------------------------------|------------------------------------|--------|--------------------|
| Ophthalmic | P | P | P | P | P | P | P | P | P | MtF329 | 6, 8, 9 |
| Fetal | MtF329 | MtF329 | MtF329 | MtF329 | MtF329 | MtF329 | MtF329 | MtF329 | MtF329 | MtF346 | 6, 8, 9 |
| Abdominal | P | P | P | P | P | P | P | P | P | MtF329 | 6, 8, 9 |
| Intraoperative (Abdominal) | | | | | | | | | | | |
| Intraoperative Neurological | | | | | | | | | | | |
| Pediatric | P | P | P | P | P | P | P | P | P | MtF329 | 6, 8, 9 |
| Small Organ [1] | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | |
| Cardiac [2] | | | | | | | | | | | |
| Transesophageal (Cardiac) | | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | | |
| Transrectal | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | |
| Peripheral Vascular | P | P | P | P | P | P | P | P | P | MtF329 | 6, 8, 9 |
| Laparoscopic | | | | | | | | | | | |
| Musculo-skeletal Conventional [3] | | | | | | | | | | | |
| Musculo-skeletal Superficial [3] | | | | | | | | | | | |
| Other (Urological) | P | P | P | P | P | P | P | P | P | MtF329 | 6, 8, 9 |

Clearspring

Combined modes are:

R+Σ+CE+M+PD

REI 30°-MRF350

[4] Combine New; Previous
BAMombineElimondows are:
[6] 3D = With 336
[6] 3D = With 336
[8] ViPan = MTF 3360
[8] ViPan = MTF 3350
[9] XView = MTF 3336
[9] XView = MTF 3336

PIXYVIEW - MITES36

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

23

70 - CA621

Mode of Operations
nical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity Mapping
(TVM)Tissue Enhacement Imaging
(TEI)CnTlOther
(specify)
Ophthalmic
RetinalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K051308MtF3236, 8, 9
AbdominalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K051308MtF3236, 8, 9
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricMtf347Mtf347Mtf347Mtf347Mtf347P
Mtf347Mtf3476, 8, 9
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K051308MtF3236, 8, 9
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K051308MtF3236, 8, 9

= Now, Previously Cleared, or Day PSA

  1. combined modes are:

[4] Combined modes are:
B+M+PW+CFM+PW+CFM+PD
[6] 3D -- MTF 355
[6] 3D -- MTF 3325
[8] VPan -- MTF 3323
[9] XView - MTF 335

B+M+PW+CF+N+PC
RT13D. VET. SEC.

(6) 3D-MTF 356

[8] Yvan - MTF 32

[a] XYIpw - MTF33/3

Concurrence of CDRH, Office of Device Evaluation (ODB

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

24

0-CA631
Mode of Operations
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
FetalMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
P6, 8, 9
AbdominalMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
P6, 8, 9
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Transvascular
Peripheral VascularMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
P6, 8, 9
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)MtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
PMtF356
P6, 8, 9

e:
combined modes

RAM+BK+CEM+BD
[E], COMBINED RISKS

B+t+d+∞+p+CF+CF+p+d

(63D-MTE356)

[8] ypan - MTF356

[8] Years - MIPS 333

(a) YYVdK-MTF350

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

Division of Reproductive, Abdominal
Radiological Devices
510(K) Number K08138

Division of
Radiological Devices
510(K) Number

25

23
1
I
EC
l
0
L
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
FetalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PK051308
PMtF323
P6, 8, 9
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
Pediatric
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
TransrectalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PK051308
PMtF323
P6, 8, 9
TransvaginalP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PK051308
PMtF323
P6, 8, 9
Transurethral
Intravascular
Peripheral Vascular
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323
PK051308
PMtF323
P6, 8, 9
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
Scrotal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricPMtF329PPMtF329MtF329MTF 3296, 8, 9, 13
Small Organ [1]PMtF329PPMtF329MtF329MTF 3296, 8, 9, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularPMtF329PPMtF329MtF329MTF 3296, 8, 9, 13
Laparoscopic
Musculo-skeletal Conventional [3]PMtF329PPMtF329MtF329MTF 3296, 8, 9, 13
Musculo-skeletal Superficial [3]PMtF329PPMtF329MtF329MTF 3296, 8, 9, 13
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTlOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF 3236,8,9,13
Intraoperative Neurological
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF 3236,8,9,13
Small Organ [1]
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308MTF3236, 8, 9, 13, 14
LaparoscopicP
K051308P
K051308P
K051308
Musculo-skeletal Conventional [3]P
K051308P
K051308PPPMTF 3236, 8, 9, 13
Musculo-skeletal Superficial [3]P
K051308P
K051308P
K051308P
K051308P
KOS1308P
K051308MTF 3236, 8, 9, 13
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308Mtf323K051308P6, 8, 9, 13
Small Organ [1]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308Mtf323K051308P6, 8, 9, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Intravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308PP
K051308Mtf323K051308P6, 8, 9, 13, 14
Laparoscopic
Musculo-skeletal Conventional [3]P
K051308P
K051308P
K051308P
K051308PP
K051308Mtf323K051308P6, 8, 9, 13
Musculo-skeletal Superficial [3]P
K051308P
K051308P
K051308P
K051308PP
K051308Mtf323K051308P6, 8, 9, 13
Other (Urological)
Clinical ApplicationBMPWDCWDColor DopplerAmplitude DopplerCombined [4]Color Velocity Mapping (TVM)Tissue Enhacement Imaging (TEI)CnTIOther (specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K0513086, 8, 9, 13
Small Organ [1]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K0513086, 8, 9, 13
Neonatal Cephalic
Adult Cephalic
Cardiac [2]
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Travascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF323P
K0513086, 8, 9, 13
Laparoscopic
Musculo-skeletal Conventional [3]P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF3566, 8, 9, 13
Musculo-skeletal Superficial [3]P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF356P
MtF3566, 8, 9, 13
Oher (Urological)
70-PA122Mode of Operations
Clinical ApplicationBMPWDCWDColor DopplerAmplitude
DopplerCombined [4]Color Velocity
Mapping (TVM)Tissue Enhacement Imaging
(TEI)CnTIOther
(specify)
Ophthalmic
Fetal
Abdominal
Intraoperative (Abdominal)
Intraoperative Neurological
PediatricP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF 323
P6, 9
Small Organ [1]
Neonatal CephalicP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF 323
P6, 9
Adult Cephalic
Cardiac [2]P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MtF356
PMTF 323
P6, 9
Transesophageal (Cardiac)
Transesophageal (Non Cardiac)
Transrectal
Transvaginal
Transurethral
Extravascular
Peripheral VascularP
K051308P
K051308P
K051308P
K051308P
K051308P
K051308P
K051308MTF 323
P6, 9
Laparoscopic
Musculo-skeletal Conventional [3]
Musculo-skeletal Superficial [3]
Other (Urological)

N = New; P = Previously Cleared by FD.

  1. Combined modes are:

B+M+PW+CFM+PD

B+MF+NITED
[5] 30, MITE 356

[6] 30 - NIF 33B
[6] 30 - NIF 33B

[8] Ypan - MJF 323

[4] Combined modes are:
B+M+PW+CFM+PW+CFM+PD
[6] 3D - MTF 3356
[6] 3D - MTF 3233
[8]] VPan - MTF 3233
[9] XView - MTF 336

Concurrence of CDRH, Office of Device Evaluation (ODE

Joh
f
(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

26

70-LA435

Human Organs includes Breast, Thyroid

[1] Small Organs includes Breast, Thyroir
and Testicles
[4] Combined modes are:
B+M+PW+CFM+PD

[13] TP-View

[6] 3D -

[8] VPən

Concurrence of CDRH, Office of Device Evaluation (ODI

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

27

70 - LA522

[1] Small (1) Small (1) Small (1) Small (1) Streation (1) Small (1)
and Teams (1) Strail of Streast, Thyrold
(1) Cardiac (8 Advint and Peediatric
B-M-Blined models are:

(9) XView
[13] TP-View

[14] IMT

oncurrence of CDRH, Office of Device Evaluation (ODE)

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

28

70 - LA523

[11] Small Organs includes Breast, Thyroid

[14] IMT - MTF 331 [8] VPan [1] Small Organs includes Breast, Thyroid
and Testicles
[2] Cardiac is Adult and Pediatric
[2] Cardiac is Adult and Pediatric
B+M+PW+CFM+PD
[6] 3D

[9] XView
[13] TP-View

[9] XView
[13] TP-View

  • . [14] IMT -

Concurrence of CDRH, Office of Device Evaluation (Ol

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

29

70 - LA532

HENRY P. PENDEXTER, FSA
Consulting Actuary by POA

N = New; P = Previously Cleared by Fleared by Fleared by Fleared by Fleared by Fleared by Fleared by Fleating Fresticles
and Tresticles
B+M+PW+CFM+PD

Testicles

[4] Combined modes

B+M+PW+CFM+PD

f6l3D

[f6]3D

នាគារ សានា នោះ នោះ នោះ នោះ នោះ នោះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ នេះ
នេះ

[6] MarView

Preview
[CFTP-View]

[13] TP-View

Concurrence of CDRH, Office of Device Evaluation (ODE

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

30

N = New, P = Previously Designed by P.C. fd

11 Small Organs includes Breast

[1] Small Organs includes Breast,

M) Combined modes can

[4] Combined modes are:
B+M+PW+CW+CFM+PD
[6] 3D - MTF 356
[6] 3D - MTF 356
[9] XView - MTF 356
[9] XView - MTF 336

Concurrence of CDRH, Office of Device Evaluation (OD

(Division Sign-Off) V
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081386

31

0
A23
d
I
0
1

| Clinical Application | B | M | PWD | CWD | Color Doppler | Amplitude
Doppler (PD) | Combined [4] | Color Velocity
Mapping (TVM) | Tissue
Enhancement
Imaging (TEI) | CnTI | Other
(specify) | |
|-----------------------------------|-------------|-------------|-------------|-------------|---------------|---------------------------|--------------|---------------------------------|----------------------------------------|-------------|--------------------|------|
| Ophthalmic | P | P | P | P | P | P | P | P
MtF323 | K051308 | P
MtF323 | 6, 9 | |
| Fetal | P | P | P | P | P | P | P | P
MtF323 | K051308 | P
MtF323 | 6, 9 | |
| Abdominal | P | P | P | P | P | P | P | P
MtF323 | K051308 | P
MtF323 | 6, 9 | |
| Intraoperative (Abdominal) | P | P | P | P | P | P | P | P
MtF323 | K051308 | P
MtF323 | 6, 9 | |
| Intraoperative Neurological | | | | | | | | | | | | |
| Pediatric | | | | | | | | | | | | |
| Small Organ [1] | | | | | | | | | | | | |
| Neonatal Cephalic | | | | | | | | | | | | |
| Adult Cephalic | | | | | | | | | | | | |
| Cardiac [2] | | | | | | | | | | | | |
| Transesophageal (Cardiac) | | | | | | | | | | | | |
| Transesophageal (Non Cardiac) | | | | | | | | | | | | |
| Transrectal | | | | | | | | | | | | |
| Transvaginal | | | | | | | | | | | | |
| Transurethral | | | | | | | | | | | | |
| Intravascular | | | | | | | | | | | | |
| Peripheral Vascular | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | P
MtF356 | 6, 9 |
| Laparoscopic | | | | | | | | | | | | |
| Musculo-skeletal Conventional [3] | | | | | | | | | | | | |
| Musculo-skeletal Superficial [3] | | | | | | | | | | | | |
| Other (Urological) | | | | | | | | | | | | |

(2) Cardian N = New; P = Previously Cleared by FDA
(4) Combac is Adult and Pediatric
(4) Combined moders are aradiatric
B+M+PWined moders (2) CPM+PD
(6] 3D -MTF 3356

[22] Cancer is Adult and Pediatric

[4] Combined modes are:

R+M+PY+CW+CEM+2D

[25] 3D MTE 255

[b]-R1t-330

[9] xyview - MTF336

Concurrence of CDRH, Office of Device Evaluation (OD

(Division Sign-Off)
Division of Reproductive, Abdominal and
Radiological Devices
510(k) Number
K081384